AIXTRON SE - AIXA.DE

AIXA.DE Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
AIXA.DE	1.2	-2.0	-8.8	-7.6	-32.3	-60.9	-24.8	46.4	86.0	-51.4
S&P 500	-0.3	1.4	1.1	5.0	11.8	24.7	40.3	88.1	196.6	34448.4

Compare AIXA.DE with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	AIXA.DE
name	AIXTRON SE
price	13.91
changes percentage	1.1636
change	0.16
day low	13.675
day high	14
year high	36.18
year low	12.73
market cap	1565982208
price avg 50	14.4475
price avg 200	17.602724
exchange	XETRA
volume	636481
avg volume	745036
open	13.85
previous close	13.75
eps	1.02
pe	13.64
earnings announcement	2025-02-26T06:30:00.000+0000
shares outstanding	112579598
timestamp	2025-01-24 16:35:19

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 64.3%

Overall Quarterly Financial Health: 64.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	629879000	463167000	35.99
gross profit	279032000	195271000	42.89
gross profit ratio	0.44	0.42	5.07
research and development expenses	87681000	57726000	51.89
operating expenses	122265000	92539000	32.12
interest income	1119000	803000	39.35
interest expense	205000	356000	-42.42
ebitda	169496000	114366000	48.20
ebitdaratio	0.27	0.25	8.19
operating income	156767000	104696000	49.74
operating income ratio	0.25	0.23	10.10
net income	145185000	100437000	44.55
net income ratio	0.23	0.22	6.29
eps	1.29	0.89	44.94

Overall Score of Annual Income Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 630 million in 2023 from 463 million in 2022 representing a change of 35.99%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 279 million in 2023 from 195 million in 2022 representing a change of 42.89%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 88 million in 2023 from 58 million in 2022 representing a change of 51.89%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 122 million in 2023 from 93 million in 2022 representing a change of 32.12%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 169 million in 2023 from 114 million in 2022 representing a change of 48.2%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 157 million in 2023 from 105 million in 2022 representing a change of 49.74%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 145 million in 2023 from 100 million in 2022 representing a change of 44.55%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.29 in 2023 from 1.29 in 2022 representing a change of 44.94%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	156326000	131779000	18.63
gross profit	67093000	49112000	36.61
gross profit ratio	0.43	0.37	15.16
research and development expenses	21203000	24567000	-13.69
operating expenses	29593000	36317000	-18.51
interest income	298000	369000	-19.24
interest expense	92000	41000	124.39
ebitda	41420000	16768000	147.02
ebitdaratio	0.26	0.12	115.07
operating income	37500000	12795000	193.08
operating income ratio	0.24	0.1	147.06
net income	30904000	11130000	177.66
net income ratio	0.2	0.08	134.06
eps	0.27	0.1	173.00

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 156 million in 2024Q3 from 132 million in 2024Q2 representing a change of 18.63%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 67 million in 2024Q3 from 49 million in 2024Q2 representing a change of 36.61%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 30 million in 2024Q3 from 36 million in 2024Q2 representing a change of -18.51%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 41 million in 2024Q3 from 17 million in 2024Q2 representing a change of 147.02%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 38 million in 2024Q3 from 13 million in 2024Q2 representing a change of 193.08%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 31 million in 2024Q3 from 11 million in 2024Q2 representing a change of 177.66%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.27 in 2024Q3 from 0.27 in 2024Q2 representing a change of 173.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 21 million in 2024Q3 from 25 million in 2024Q2 representing a change of -13.69%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1029945999	902577000	14.11
total liabilities	252368000	239260000	5.48
total equity	777578000	663317000	17.23
cash and cash equivalents	98022000	104751000	-6.42
short term investments	83655000	220410000	-62.05
long term investments	707000	705000	0.28
total current assets	763668000	692907000	10.21
total non current assets	266277999	209670000	27.00
total current liabilities	244625000	229268000	6.70
total non current liabilities	7743000	9992000	-22.51
common stock	112535000	112383000	0.14
retained earnings	265531000	155231000	71.06
total debt	5436000	7962000	-31.73

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,030 million in 2023 from 903 million in 2022 representing a change of 14.11%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 778 million in 2023 from 663 million in 2022 representing a change of 17.23%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 764 million in 2023 from 693 million in 2022 representing a change of 10.21%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 113 in 2023 from 112 in 2022 representing a change of 0.14%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 266 million in 2023 from 155 million in 2022 representing a change of 71.06%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 5 million in 2023 from 8 million in 2022 representing a change of -31.73%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 252 million in 2023 from 239 million in 2022 representing a change of 5.48%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 98 million in 2023 from 105 million in 2022 representing a change of -6.42%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 84 million in 2023 from 220 million in 2022 representing a change of -62.05%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 245 million in 2023 from 229 million in 2022 representing a change of 6.7%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	1002205000	1012221000	-0.99
total liabilities	212355000	254098000	-16.43
total equity	789850000	758123000	4.18
cash and cash equivalents	77579000	78884000	-1.65
short term investments	506000	501000	1.00
long term investments	697000	734000	-5.04
total current assets	657729000	679675000	-3.23
total non current assets	344476000	332546000	3.59
total current liabilities	205059000	246554000	-16.83
total non current liabilities	7295999	7544000	-3.29
common stock	112672000	112649000	0.02
retained earnings	273377000	242473000	12.75
total debt	6405000	0	NaN

Overall Score of Quarterly Balance Sheet

0.6 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,002 million in 2024Q3 from 1,012 million in 2024Q2 representing a change of -0.99%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 78 million in 2024Q3 from 79 million in 2024Q2 representing a change of -1.65%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 658 million in 2024Q3 from 680 million in 2024Q2 representing a change of -3.23%. This indicates a worsen liquidity position.

  Total Debt: Total Debt increased to 6 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 212 million in 2024Q3 from 254 million in 2024Q2 representing a change of -16.43%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 790 million in 2024Q3 from 758 million in 2024Q2 representing a change of 4.18%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of 1.0%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 205 million in 2024Q3 from 247 million in 2024Q2 representing a change of -16.83%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 113 in 2024Q3 from 113 in 2024Q2 representing a change of 0.02%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 273 million in 2024Q3 from 242 million in 2024Q2 representing a change of 12.75%. This indicates an accumulated profits.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-6729000	-46112000	85.41
operating cash flow	-47289000	37139000	-227.33
free cash flow	-109934000	7477000	-1570.30
capital expenditure	-62645000	-29662000	-111.20
depreciation and amortization	11610000	8867000	30.93
deferred income tax	-7191000	-9222000	22.02
stock based compensation	4762000	4441000	7.23
accounts payables	12267000	27102000	-54.74
inventory	-170852000	-103633000	-64.86
acquisitions net	0	186000	-100.00
investments in property plant and equipment	-62645000	-29662000	-111.20
net cash used for investing activites	78118000	-48271000	261.83
debt repayment	0	0	NaN
common stock issued	827000	741000	11.61
common stock repurchased	0	0	NaN
dividends paid	-34839000	-33662000	-3.50
net cash used provided by financing activities	-35881000	-34592000	-3.73
cash at end of period	98022000	104751000	-6.42
accounts receivables	-38758000	-39987000	3.07
cash at beginning of period	104751000	150863000	-30.57

Overall Score of Annual Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -7 million in 2023 from -46 million in 2022 representing a change of 85.41%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -63 million in 2023 from -30 million in 2022 representing a change of -111.2%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 12 million in 2023 from 27 million in 2022 representing a change of -54.74%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to -47 million in 2023 from 37 million in 2022 representing a change of -227.33%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -110 million in 2023 from 7 million in 2022 representing a change of -1570.3%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to -7 million in 2023 from -9 million in 2022 representing a change of 22.02%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 5 million in 2023 from 4 million in 2022 representing a change of 7.23%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to -39 in 2023 from -40 million in 2022 representing a change of 3.07%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -35 million in 2023 from -34 million in 2022 representing a change of -3.5%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	15682000	20534000	-23.63
free cash flow	-908000	-22983000	96.05
capital expenditure	-16590000	-43517000	61.88
depreciation and amortization	3622000	3440000	5.29
deferred income tax	2100000	-420000	600.00
stock based compensation	0	1045000	-100.00
accounts receivables	859000	662000	29.76
accounts payables	-35026000	18724000	-287.06
inventory	21873000	-11237000	294.65
acquisitions net	0	0	NaN
investments in property plant and equipment	-17023000	-43517000	60.88
net cash used for investing activites	-16963000	9798000	-273.13
debt repayment	0	0	NaN
common stock issued	309000	230000	34.35
common stock repurchased	0	0	NaN
dividends paid	0	-45033000	100.00
net cash used provided by financing activities	-98000	-45238000	99.78
net change in cash	-1305000	-15319000	91.48
cash at end of period	77579000	78884000	-1.65
cash at beginning of period	78884000	94203000	-16.26

Overall Score of Quarterly Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -1 million in 2024Q3 from -15 million in 2024Q2 representing a change of 91.48%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Free Cash Flow: Free Cash Flow increased to -1 million in 2024Q3 from -23 million in 2024Q2 representing a change of 96.05%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q3 from 1 million in 2024Q2 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q3 from -45 million in 2024Q2 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 16 million in 2024Q3 from 21 million in 2024Q2 representing a change of -23.63%. This indicates that the company generated less cash from its core business operations.

  Capital Expenditure: Capital Expenditure increased to -17 million in 2024Q3 from -44 million in 2024Q2 representing a change of 61.88%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 2 million in 2024Q3 from 0 million in 2024Q2 representing a change of 600.0%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 35 million in 2024Q3 from 19 million in 2024Q2 representing a change of -287.06%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 1 in 2024Q3 from 1 million in 2024Q2 representing a change of 29.76%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	5.6	4.12	35.79
net income per share	1.29	0.89	44.34
operating cash flow per share	-0.42	0.33	-227.14
free cash flow per share	-0.98	0.07	-1568.09
cash per share	1.62	2.9	-44.21
book value per share	6.91	5.91	17.05
tangible book value per share	6.23	5.23	19.09
shareholders equity per share	6.91	5.9	17.05
interest debt per share	0.05	0.07	-32.29
market cap	4164614535.83	3028652328.51	37.51
enterprise value	4072028535.83	2931863328.51	38.89
pe ratio	28.68	30.15	-4.87
price to sales ratio	6.61	6.54	1.11
pocfratio	-88.07	81.55	-207.99
pfcf ratio	-37.88	405.06	-109.35
pb ratio	5.36	4.57	17.30
ptb ratio	5.36	4.57	17.30
ev to sales	6.46	6.33	2.13
enterprise value over ebitda	24.02	25.64	-6.29
ev to operating cash flow	-86.11	78.94	-209.08
ev to free cash flow	-37.04	392.12	-109.45
earnings yield	0.03	0.03	5.12
free cash flow yield	-0.03	0.0	-1169.25
debt to equity	0.01	0.01	-41.76
debt to assets	0.01	0.01	-40.17
net debt to ebitda	-0.55	-0.85	35.46
current ratio	3.12	3.02	3.29
interest coverage	764.72	294.09	160.03
income quality	-0.33	0.37	-188.12
dividend yield	0.01	0.01	-24.73
payout ratio	0.24	0.34	-28.40
sales general and administrative to revenue	0.05	0.06	-18.02
research and ddevelopement to revenue	0.14	0.12	11.69
intangibles to total assets	0.07	0.08	-11.20
capex to operating cash flow	-1.32	0.8	-265.87
capex to revenue	0.1	0.06	55.30
capex to depreciation	5.4	3.35	61.30
stock based compensation to revenue	0.01	0.01	-21.15
graham number	14.17	10.9	29.98
roic	0.18	0.19	-5.13
return on tangible assets	0.15	0.12	25.39
graham net net	2.3	2.56	-10.33
working capital	519043000	463639000	11.95
tangible asset value	700849999	587598000	19.27
net current asset value	511300000	453647000	12.71
invested capital	743522000	638338000	16.48
average receivables	147598500	100329000	47.11
average payables	51929500	32841500	58.12
average inventory	309027500	172111500	79.55
days sales outstanding	101.7	94.33	7.82
days payables outstanding	60.09	62.81	-4.32
days of inventory on hand	410.37	304.64	34.71
receivables turnover	3.59	3.87	-7.25
payables turnover	6.07	5.81	4.52
inventory turnover	0.89	1.2	-25.77
roe	0.19	0.15	23.31
capex per share	0.56	0.26	110.88

• Positive

  ROE: Return on Equity (ROE) increased to 0.19 on 2023-12-31 from 0.15 on 2022-12-31, representing a change of 23.31%. Suggesting the company has been generating high returns for its shareholders.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.01 on 2023-12-31 from 0.01 on 2022-12-31, representing a change of -41.76%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 28.68 on 2023-12-31 from 30.15 on 2022-12-31, representing a change of -4.87%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 3.12 on 2023-12-31 from 3.02 on 2022-12-31, representing a change of 3.29%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
AIXA.DE
calendar year	2024	2024	NaN
revenue per share	1.37	1.17	16.66
net income per share	0.27	0.1	173.05
operating cash flow per share	0.14	0.18	-24.90
free cash flow per share	-0.01	-0.2	96.11
cash per share	0.68	0.71	-3.27
book value per share	6.9	6.74	2.45
tangible book value per share	6.22	6.04	2.96
shareholders equity per share	6.9	6.73	2.45
interest debt per share	0.06	0.0	15482.87
market cap	1826769773.64	2021509675.28	-9.63
enterprise value	1755595773.64	1942625675.28	-9.63
pe ratio	14.78	45.41	-67.45
price to sales ratio	11.69	15.34	-23.82
pocfratio	116.49	98.45	18.33
pfcf ratio	-2011.86	-87.96	-2187.33
pb ratio	2.31	2.67	-13.26
ptb ratio	2.31	2.67	-13.26
ev to sales	11.23	14.74	-23.82
enterprise value over ebitda	42.39	115.85	-63.41
ev to operating cash flow	111.95	94.61	18.33
ev to free cash flow	-1933.48	-84.52	-2187.47
earnings yield	0.02	0.01	207.26
free cash flow yield	-0.0	-0.01	95.63
debt to equity	0.01	0	NaN
debt to assets	0.01	0	NaN
net debt to ebitda	-1.72	-4.7	63.47
current ratio	3.21	2.76	16.35
interest coverage	407.61	312.07	30.61
income quality	0.51	1.84	-72.49
dividend yield	0	0.02	-100.00
payout ratio	0	4.05	-100.00
sales general and administrative to revenue	0.05	0.06	-14.37
research and ddevelopement to revenue	0.14	0.19	-27.25
intangibles to total assets	0.08	0.08	0.70
capex to operating cash flow	1.06	2.12	-50.08
capex to revenue	0.11	0.33	-67.86
capex to depreciation	4.58	12.65	-63.79
stock based compensation to revenue	0	0.01	-100.00
graham number	6.47	3.87	67.26
roic	0.04	0.01	172.79
return on tangible assets	0.03	0.01	180.60
graham net net	0.69	1.22	-43.22
working capital	452670000	433121000	4.51
tangible asset value	711812000	679856000	4.70
net current asset value	445374000	425577000	4.65
invested capital	755009000	721207000	4.69
average receivables	58484000	120181000	-51.34
average payables	55931500	63935500	-12.52
average inventory	437344500	442190000	-1.10
days sales outstanding	0	79.88	-100.00
days payables outstanding	39.31	79.35	-50.45
days of inventory on hand	430.41	487.68	-11.74
receivables turnover	0	1.13	-100.00
payables turnover	2.29	1.13	101.83
inventory turnover	0.21	0.18	13.31
roe	0.04	0.01	166.51
capex per share	0.14	0.39	-62.51

• Negative

  ROE: Return on Equity (ROE) increased to 0.04 on 2024-09-30 Q3 from 0.01 on 2024-06-30 Q2, representing a change of 166.51%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 14.78 on 2024-09-30 Q3 from 45.41 on 2024-06-30 Q2, representing a change of -67.45%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 3.21 on 2024-09-30 Q3 from 2.76 on 2024-06-30 Q2, representing a change of 16.35%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is -13.87 which is lower than current price 13.91, indicates the company may be overvalued.